Subgroup Analysis Of Patients Participating In The Aethera Trial: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study Of Brentuximab Vedotin In Patients At Risk Of Progression Following Autologous Stem Cell Transplant For Hodgkin Lymphoma
BONE MARROW TRANSPLANTATION(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要